Skip to content

VanishPoint® 15221Recalls & reported problems

Retractable Technologies, Inc. · 0.5mL 30G x 1/2" Insulin VanishPoint® Syringe · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00613703152206), received between Dec 18, 2018 and Dec 18, 2018 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Contamination with Chemical or Other Material” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Device Contamination with Chemical or Other Material1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 18, 2018Device Contamination with Chemical or Other Material

    WHEN DRAWING UP INSULIN, RN NOTICED THAT THERE WAS A LONG PIECE OF METAL AGAINST THE INSIDE OF THE SYRINGE.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8174026 ↗

Other Syringe, Antistick devices

All Syringe, Antistick devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.